Urologic Oncology: Seminars and Original Investigations
Volume 30, Issue 3 , Pages 273-277 , May 2012

Role of fluorescence in situ hybridization in bladder cancer surveillance of patients with negative cytology

  • Ramy F. Youssef, M.D.

      Affiliations

    • Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
    • ,
  • Bruce J. Schlomer, M.D.

      Affiliations

    • Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
    • ,
  • Richard Ho, B.S.

      Affiliations

    • Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
    • ,
  • Arthur I. Sagalowsky, M.D.

      Affiliations

    • Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
    • ,
  • Raheela Ashfaq, M.D.

      Affiliations

    • Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
    • ,
  • Yair Lotan, M.D.

      Affiliations

    • Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-214-648-0389; fax: +1-214-648-8786

Received 22 December 2009 ,Revised 13 February 2010 ,Accepted 18 February 2010.

References 

  1. Jemal A , Siegel R , Ward E , et al.  Cancer statistics, 2008 . CA Cancer J Clin . 2008;58:71–96
  2. Hong YM , Loughlin KR . Economic impact of tumor markers in bladder cancer surveillance . Urology . 2008;71:131–135
  3. van Rhijn BW , Burger M , Lotan Y , et al.  Recurrence and progression of disease in non-muscle-invasive bladder cancer: From epidemiology to treatment strategy . Eur Urol . 2009;56:430–442
  4. Babjuk M , Oosterlinck W , Sylvester R , et al.  EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder . Eur Urol . 2008;54:303–314
  5. Halling KC , King W , Sokolova IA , et al.  A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma . J Urol . 2000;164:1768–1775
  6. Lotan Y , Roehrborn CG . Sensitivity and specificity of commonly available bladder tumor markers vs. cytology: Results of a comprehensive literature review and meta-analyses . Urology . 2003;61:109–118
  7. Lotan Y , Bensalah K , Ruddell T , et al.  Prospective evaluation of the clinical usefulness of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder . J Urol . 2008;179:2164–2169
  8. Pycha A . FISH: A tool we really need? . Eur Urol . 2007;52:630–632
  9. Sarosdy MF , Kahn PR , Ziffer MD , et al.  Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria . J Urol . 2006;176:44–47
  10. Skacel M , Fahmy M , Brainard JA , et al.  Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology . J Urol . 2003;169:2101–2105
  11. Lokeshwar VB , Habuchi T , Grossman HB , et al.  Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers . Urology . 2005;66(6 Suppl 1):35–63
  12. Schlomer BJ , Ho R , Sagalowsky A , et al.  Prospective validation of the clinical utility of reflex fluorescence in situ hybridization assay in patients with atypical cytology for the detection of urothelial carcinoma of the bladder. J Urol . 2010; accepted for publication
  13. Yoder BJ , Skacel M , Hedgepeth R , et al.  Reflex UroVysion testing of bladder cancer surveillance patients with equivocal or negative urine cytology: A prospective study with focus on the natural history of anticipatory positive findings . Am J Clin Pathol . 2007;127:295–301
  14. Daniely M , Rona R , Kaplan T , et al.  Combined analysis of morphology and fluorescence in situ hybridization significantly increases accuracy of bladder cancer detection in voided urine samples . Urology . 2005;66:1354–1359
  15. Guney S , Guney N , Canogullari Z , et al.  Ta T1 low and intermediate transitional cell carcinoma of the bladder: Recurrence rates and the timing of check cystoscopies within the first year . Urol Int . 2008;80:124–128
  16. Oge O , Erdem E , Atsü N , et al.  Proposal for changes in cystoscopic follow-up of patients with low-grade pTa bladder tumor . Eur Urol . 2000;37:271–274
  17. Sarosdy MF , Schellhammer P , Bokinsky G , et al.  Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer . J Urol . 2002;168:1950–1954
  18. Laudadio J , Keane TE , Reeves HM , et al.  Fluorescence in situ hybridization for detecting transitional cell carcinoma: Implications for clinical practice . BJU Int . 2005;96:1280–1285
  19. Nguyen CT , Litt DB , Dolar SE , et al.  Prognostic significance of nondiagnostic molecular changes in urine detected by UroVysion fluorescence in situ hybridization during surveillance for bladder cancer . Urology . 2009;73:347–350
  20. Ferra S , Denley R , Herr H , et al.  Reflex UroVysion testing in suspicious urine cytology cases . Cancer Cytopathol . 2009;117:7–14

PII: S1078-1439(10)00054-2

doi: 10.1016/j.urolonc.2010.02.012

Urologic Oncology: Seminars and Original Investigations
Volume 30, Issue 3 , Pages 273-277 , May 2012

Article Tools